FIELD: medicine, chemistry of peptides.
SUBSTANCE: invention proposes a new anti-arrhythmic agent that represents a peptide ligand of opioid receptors deltorphine D - compound of the formula (I): Tyr-D-Leu-Phe-Ala-Asp-Val-Ala-Ser-Thr-Ile-Gly-Asp-Phe-His-Ser-Ile-NH2 (I). The effect of this agent is associated with stimulation of opioid receptors and results to reducing frequency in arising multiple ventricular extrasystoles and episodes of ventricular tachycardia.
EFFECT: valuable medicinal properties of agent.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-ARRHYTHMIC AGENT | 2003 |
|
RU2235553C1 |
ANTI-ARRHYTHMIC AGENT | 2005 |
|
RU2320342C2 |
ANTI-ARRHYTHMIC AGENT | 2001 |
|
RU2195275C1 |
ANTIARRHYTHMIC AGENT | 1998 |
|
RU2171115C2 |
AGENT FOR INCREASING RESISTANCE OF HEART TO ARRYTHMOGENIC ACTION OF ISCHAEMIA AND REPERFUSION | 2014 |
|
RU2587783C1 |
AGENT POSSESSING ANTIARRHYTHMIC ACTION | 2019 |
|
RU2700263C1 |
PREPARATION FOR TREATING ARRHYTHMIA | 1998 |
|
RU2163807C2 |
METHOD FOR SIMULATION OF INCREASED STABILITY OF RAT MYOCARDIUM TO ISCHEMIC-REPERFUSION DAMAGE | 2016 |
|
RU2623727C1 |
CARDIOPROTECTIVE AND ANTIARRHYTHMIC MEDICINE | 2022 |
|
RU2783444C1 |
CARDIOTONIC PREPARATION | 1998 |
|
RU2163817C2 |
Authors
Dates
2005-09-20—Published
2004-02-03—Filed